These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35410627)

  • 1. Menstrual blood-derived mesenchymal stromal cells efficiently ameliorate experimental autoimmune encephalomyelitis by inhibiting T cell activation in mice.
    Li Y; Gao H; Brunner TM; Hu X; Yan Y; Liu Y; Qiao L; Wu P; Li M; Liu Q; Yang F; Lin J; Löhning M; Shen P
    Stem Cell Res Ther; 2022 Apr; 13(1):155. PubMed ID: 35410627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
    Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
    Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose-derived mesenchymal stem cells ameliorates experimental autoimmune encephalomyelitis via modulation of Th1/Th17 and expansion of Th2/Treg responses.
    Zargarani S; Tavaf MJ; Soltanmohammadi A; Yazdanpanah E; Baharlou R; Yousefi B; Sadighimoghaddam B; Esmaeili SA; Haghmorad D
    Cell Biol Int; 2024 Aug; 48(8):1124-1137. PubMed ID: 38741520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE.
    Vega-Letter AM; Kurte M; Fernández-O'Ryan C; Gauthier-Abeliuk M; Fuenzalida P; Moya-Uribe I; Altamirano C; Figueroa F; Irarrázabal C; Carrión F
    Stem Cell Res Ther; 2016 Oct; 7(1):150. PubMed ID: 27724984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural stem cells derived from primitive mesenchymal stem cells reversed disease symptoms and promoted neurogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
    Brown C; McKee C; Halassy S; Kojan S; Feinstein DL; Chaudhry GR
    Stem Cell Res Ther; 2021 Sep; 12(1):499. PubMed ID: 34503569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis.
    Togha M; Jahanshahi M; Alizadeh L; Jahromi SR; Vakilzadeh G; Alipour B; Gorji A; Ghaemi A
    Mol Neurobiol; 2017 May; 54(4):2445-2457. PubMed ID: 26971291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
    Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis.
    Bravo B; Gallego MI; Flores AI; Bornstein R; Puente-Bedia A; Hernández J; de la Torre P; García-Zaragoza E; Perez-Tavarez R; Grande J; Ballester A; Ballester S
    Stem Cell Res Ther; 2016 Mar; 7():43. PubMed ID: 26987803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE).
    Yousefi F; Ebtekar M; Soleimani M; Soudi S; Hashemi SM
    Int Immunopharmacol; 2013 Nov; 17(3):608-16. PubMed ID: 23973288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.
    Liao W; Pham V; Liu L; Riazifar M; Pone EJ; Zhang SX; Ma F; Lu M; Walsh CM; Zhao W
    Biomaterials; 2016 Jan; 77():87-97. PubMed ID: 26584349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors.
    Kassis I; Petrou P; Halimi M; Karussis D
    Immunol Lett; 2013; 154(1-2):70-6. PubMed ID: 23994102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal Stromal/Stem Cells Do Not Ameliorate Experimental Autoimmune Encephalomyelitis and Are Not Detectable in the Central Nervous System of Transplanted Mice.
    Abramowski P; Krasemann S; Ernst T; Lange C; Ittrich H; Schweizer M; Zander AR; Martin R; Fehse B
    Stem Cells Dev; 2016 Aug; 25(15):1134-48. PubMed ID: 27250994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis.
    Kurte M; Luz-Crawford P; Vega-Letter AM; Contreras RA; Tejedor G; Elizondo-Vega R; Martinez-Viola L; Fernández-O'Ryan C; Figueroa FE; Jorgensen C; Djouad F; Carrión F
    Front Immunol; 2018; 9():802. PubMed ID: 29760692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparate Effects of Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis and Cuprizone-Induced Demyelination.
    Glenn JD; Smith MD; Kirby LA; Baxi EG; Whartenby KA
    PLoS One; 2015; 10(9):e0139008. PubMed ID: 26407166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-Reactive Protein Suppresses the Th17 Response Indirectly by Attenuating the Antigen Presentation Ability of Monocyte Derived Dendritic Cells in Experimental Autoimmune Encephalomyelitis.
    Shen ZY; Zheng Y; Pecsok MK; Wang K; Li W; Gong MJ; Wu F; Zhang L
    Front Immunol; 2021; 12():589200. PubMed ID: 33841391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraperitoneal injection of mesenchymal stem cells-conditioned media (MSCS-CM) treated monocyte can potentially alleviate motor defects in experimental autoimmune encephalomyelitis female mice; An original experimental study.
    Jalali Kondori B; Abdolmaleki A; Raei M; Ghorbani Alvanegh A; Esmaeili Gouvarchin Ghaleh H
    Transpl Immunol; 2024 Aug; 85():102067. PubMed ID: 38839021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy regulates the therapeutic potential of mesenchymal stem cells in experimental autoimmune encephalomyelitis.
    Dang S; Xu H; Xu C; Cai W; Li Q; Cheng Y; Jin M; Wang RX; Peng Y; Zhang Y; Wu C; He X; Wan B; Zhang Y
    Autophagy; 2014 Jul; 10(7):1301-15. PubMed ID: 24905997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNS disease diminishes the therapeutic functionality of bone marrow mesenchymal stem cells.
    Sargent A; Bai L; Shano G; Karl M; Garrison E; Ranasinghe L; Planchon SM; Cohen J; Miller RH
    Exp Neurol; 2017 Sep; 295():222-232. PubMed ID: 28602834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective combination of human bone marrow mesenchymal stem cells and minocycline in experimental autoimmune encephalomyelitis mice.
    Hou Y; Ryu CH; Park KY; Kim SM; Jeong CH; Jeun SS
    Stem Cell Res Ther; 2013 Jul; 4(4):77. PubMed ID: 23826999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal delivery of central nervous system-retargeted human mesenchymal stromal cells prolongs treatment efficacy of experimental autoimmune encephalomyelitis.
    Fransson M; Piras E; Wang H; Burman J; Duprez I; Harris RA; LeBlanc K; Magnusson PU; Brittebo E; Loskog AS
    Immunology; 2014 Jul; 142(3):431-41. PubMed ID: 24588452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.